Published on 16 January 2023
Description:
Healthcare’s rising challenges and the use of digital innovation. ASH 2022: five trends driving changes in haematology, the benefits of biosimilars.
Categories:
Pharmaceutical Market EuropePreview:
28 articles from this collection:
PME JANUARY 2023
2 - PMLIVE PME
3 - Comment
4 - PMLIVE
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Microfoundations matter
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - A bundle of nerves
14 - MIKE DIXON - Making New Year resolutions that can also benefit others
15 - PHARMA STRATEGIST’S BLOG - Making a human connection – the lost art of the brand narrative
16-17 - ASH 2022 CONGRESS - bad blood but big advances
18-19 - IDENTIFYING RARE DISEASES - The challenges of identifying rare diseases
20-21 - TL INIZIO - Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
22-23 - BIOSIMILARS - Biosimilars and beyond: innovating for improved patient outcomes
24 - TL IQVIA - Merging global and local pharmacovigilance operations into a successful integrated approach
25 - DECEMBER Highlights
26-27 - DIGITAL INNOVATION - Meeting healthcare’s rising challenges
28 - TL INIZIO - Digital technology: a significant change in healthcare innovation
29 - TL INNOVATIVE TRIALS - Navigating the patient experience to improve retention of clinical trial participants
30-31 - STRATEGIC BEHAVIOUR - Strategic behaviour
32-33 - FLYPHARMA - FlyPharma Conference Middle East: new dates and location announced
34-36 - Appointments
37 - HEALTHCARE COMMS
38 - PHARMAFILE APP
43 - Pharma Market Europe (PME) Recruitment
39 - PHARMAROLE
40 - FLYPHARMA MIDDLE EAST
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services